BioPharmSignal logoBioPharmSignal

Biotech News

RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

RxSight (RXST)RxSightCommercial

WASHINGTON, April 08, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced, in advance of the 2026 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, that over 300,000 Light Adjustable Lens ® (LAL ®) implants have been performed since launch, marking a

Open original release

Related news

ADPTAdaptive Biotechnologies2026-05-29 11:30 EST

At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research

RXSTRxSight2026-05-06 20:05 EST

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

RXSTRxSight2026-05-19 20:10 EST

RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum

ICCMIceCure Medical2026-05-05 12:30 EST

IceCure Showcases ProSense® Cryoablation at American Society of Breast Surgeons 2026 Annual Meeting as Commercial Momentum Accelerates in the U.S. Market

STIMNeuronetics2026-04-29 20:30 EST

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

OMOutset Medical2026-04-06 20:05 EST

Outset Medical Names Derick Elliott as Executive Vice President of Commercial

CVRXCVRx2026-05-14 12:00 EST

CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy

IARTIntegra LifeSciences2026-05-05 10:00 EST

Integra LifeSciences Announces Leadership Transition

XTNTXtant Medical2026-05-06 12:00 EST

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

HYPRHyperfine2026-07-01 12:15 EST

Hyperfine Announces European Launch of Next-Generation Swoop® System

View all latest news

RxSight

RxSight is a medical device company focused on adjustable intraocular lenses for cataract surgery. Its business is built around ophthalmic procedure adoption and premium eye-care technology.

Recent company news

RXSTRxSight2026-05-19 20:10 EST

RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum

RXSTRxSight2026-05-06 20:05 EST

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

RXSTRxSight2026-04-29 20:10 EST

RxSight, Inc. to Present at the Bank of America Healthcare Conference

RXSTRxSight2026-04-22 20:10 EST

RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6

RXSTRxSight2026-04-08 20:05 EST

RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

Stock data

Close
5.64 USD
Market cap
204.5M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States